Global designer and manufacturer, Americhem exhibited at the 2nd China Plastic & Rubber Journal (CPRJ) Medical Plastic & Rubber Conference earlier this year, from 28th to 29th November.
Americhem is globally recognised for designing and manufacturing custom colour masterbatch, functional additives, engineered compounds and performance technologies.
S. Mani, director of technology and business development for Americhem - Asia Pacific, delivered a keynote speech during the event for over 300 professional delegates from the medical field on the topic of high performance engineered compounds and colouring solutions for medical devices.
“Due to strict legal provisions and high recall costs, medical device manufacturers are paying more attention to the quality of their selected materials. The global market for medical engineered compounds is expected to reach $33.5 billion by 2025. Digitalisation is transforming the industry in ways such as robotic surgery, telehealth, artificial organs, and other ground-breaking medical technologies,” commented Mani.
Americhem’s medical engineered compounds, ColorRx, have been successfully used in multiple medical device applications including surgical instruments, respiratory devices, drug delivery systems, labware and diagnostic equipment, catheters and tubing.
The range offered by Americhem means the organisation can provide the following features globally:
- Full range of biocompatible clear, tinted and opaque pre-coloured compounds
- Medical certification compliance
- Flexible thermoplastic elastomers for instrument overmould to ensure anti-slippage
- Gamma stable compounds for reduced colour shift
- Radiopaque compounds for visibility under x-ray and fluoroscopy applications
- Antimicrobials to protect against infection